Biofrontera (BFRI) Other Working Capital Changes (2022 - 2025)
Biofrontera's (BFRI) quarterly Other Working Capital Changes came in at -$137000.0 in Q4 2025, up 23.03% year-on-year from -$111351.6 in Q4 2024, and up 21.71% quarter-over-quarter from -$175000.0 in Q3 2025.
Biofrontera (BFRI) Other Working Capital Changes (2022 - 2025) Analysis & Trends
Biofrontera's Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$137000.0 for Q4 2025.
- On a quarterly basis, Other Working Capital Changes rose 23.03% year-over-year to -$137000.0 in Q4 2025; TTM through Dec 2025 was -$683000.0, a 0.87% increase from a year earlier, with the FY2025 full-year figure at -$683000.0, up 0.87% from the prior year.
- Other Working Capital Changes improved to -$137000.0 in Q4 2025 per BFRI's latest filing, from -$175000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.5 million in Q4 2023 and bottomed at -$5.2 million in Q3 2024.
- The 4-year median for Other Working Capital Changes is $43000.0 (2022), against an average of $54416.7.
- Biggest YoY gain for Other Working Capital Changes was 36.88% in 2024; the steepest drop was 47.5% in 2024.
- Year by year, Other Working Capital Changes stood at -$282000.0 in 2023, then jumped by 36.88% to -$178000.0 in 2024, then grew by 23.03% to -$137000.0 in 2025.
- Per Business Quant, the three latest BFRI Other Working Capital Changes figures stand at -$137000.0 (Q4 2025), -$175000.0 (Q3 2025), and -$192000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 495,000.00 |
| Dec 31, 2025 | 495,000.00 |
| Dec 31, 2025 | 495,000.00 |
| Sep 30, 2025 | -762,000.00 |
| Sep 30, 2025 | -762,000.00 |
| Sep 30, 2025 | -762,000.00 |
| Jun 30, 2025 | 729,000.00 |
| Jun 30, 2025 | 729,000.00 |
| Jun 30, 2025 | 729,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Sep 30, 2024 | -5.19 Mn |
| Sep 30, 2024 | -5.19 Mn |
| Sep 30, 2024 | -5.19 Mn |
| Jun 30, 2024 | -91,000.00 |
| Jun 30, 2024 | -91,000.00 |
| Jun 30, 2024 | -91,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Mar 31, 2024 | 119,000.00 |